|
|
|
|
|
|
|
| ASTRAZENECA PHARMA INDIA LIMITED |
| Regd. Office : Off Bellary Road, Hebbal, Bangalore 560 024 |
|
|
|
|
|
|
|
| AUDITED FINANCIAL RESULTS FOR
THE |
| QUARTER AND NINE MONTHS
PERIOD ENDED 30th SEPTEMBER 2003 |
|
|
|
|
|
|
Rs. in lakhs |
| Sl |
Particulars |
3 months |
Corresponding |
Year to date |
Year to date |
Previous |
| No. |
|
ended |
3 months in |
figures
for |
figures
for |
Accounting |
|
|
current |
the previous |
current |
previous |
year |
|
|
year |
year |
year |
year |
ended |
|
|
|
|
|
|
|
|
|
30.09.2003 |
30.09.2002 |
30.09.2003 |
30.09.2002 |
31.12.2002 |
|
|
(Audited) |
(Unaudited) |
(Audited) |
(Unaudited) |
(Audited) |
| 1 |
Net Sales/Income from
operations |
4435.61 |
3674.31 |
12585.38 |
9555.26 |
13617.19 |
| 2 |
Service Income |
28.45 |
25.00 |
100.96 |
93.57 |
144.55 |
| 3 |
Other Income |
84.17 |
52.31 |
304.06 |
208.44 |
307.38 |
|
|
|
|
|
|
|
| 4 |
Total Expenditure |
|
|
|
|
|
|
(a) Increase(-)/decrease(+) in
stock-in-trade |
-829.78 |
-1104.91 |
-21.37 |
-1158.42 |
-1721.54 |
|
(b) Consumption of raw and packing materials |
1248.73 |
1294.00 |
2978.08 |
2999.58 |
4376.14 |
|
(c) Purchase of finished goods |
952.83 |
1246.35 |
1624.53 |
2064.82 |
2760.45 |
|
(d) Staff cost |
671.06 |
639.85 |
2028.37 |
1830.54 |
3004.60 |
|
(e) Rates & taxes |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
(f) Excise duty |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
(e) Other expenditure |
1161.06 |
858.57 |
2827.44 |
2539.01 |
3478.34 |
|
|
|
|
|
|
|
| 5 |
Interest |
- |
- |
1.91 |
5.44 |
7.87 |
| 6 |
Depreciation |
115.89 |
111.35 |
328.94 |
326.53 |
485.33 |
| 7 |
Profit
(+) / Loss (-) before tax and prior period
expenditure (1+2+3-4-5-6) |
1228.44 |
706.41 |
3222.50 |
1249.77 |
1677.93 |
| 8 |
Prior period expenditure |
- |
- |
- |
33.21 |
- |
| 9 |
Profit(+)/Loss(-)
before tax (7-8 ) |
1228.44 |
706.41 |
3222.50 |
1216.56 |
1677.93 |
| 10 |
Provision for taxation |
346.00 |
300.00 |
1110.44 |
540.00 |
905.72 |
| 11 |
Deferred Tax
asset(+)/(liability)(-) for the period |
-4.13 |
3.00 |
-41.59 |
37.98 |
263.96 |
| 12 |
Net Profit(+) / Loss(-) for
the period (9-10+11) |
878.31 |
409.41 |
2070.47 |
714.54 |
1036.17 |
| 13 |
Paid-up Equity Share Capital |
500.00 |
500.00 |
500.00 |
500.00 |
500.00 |
|
(Face value of Rs.10 per
share) |
|
|
|
|
|
| 14 |
Reserves excluding revaluation
reserves |
- |
- |
- |
- |
7098.54 |
|
(as per Balance Sheet of previous |
|
|
|
|
|
|
accounting year) |
|
|
|
|
|
| 15 |
Basic and Diluted Earnings(+)/Loss(-) |
17.57 |
8.19 |
41.41 |
14.29 |
20.72 |
|
(Rs) per share (not
annualised) |
|
|
|
|
|
| 16 |
Aggregate of non-promoter
shareholding |
|
|
|
|
|
|
- Number of shares |
|
|
419509 |
|
|
|
- Percentage of shareholding |
|
|
8.39% |
|
|
|
|
|
|
|
|
|
|
Segmental Results |
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
Segment Revenue/ Income |
|
|
|
|
|
|
a) HealthCare |
2314.06 |
|
3664.99 |
|
|
|
b) Others |
- |
|
- |
|
|
|
|
2314.06 |
|
3664.99 |
|
|
|
Less: Intersegment Revenue |
- |
|
- |
|
|
|
Net Income for Operations |
2314.06 |
|
3664.99 |
|
|
|
|
|
|
|
|
|
| 2 |
Segments Results |
|
|
|
|
|
|
a) HealthCare |
174.19 |
|
-21.36 |
|
|
|
b) Others |
- |
|
- |
|
|
|
Total |
174.19 |
|
-21.36 |
|
|
|
|
|
|
|
|
|
|
Interest Expenses(-) |
-3.56 |
|
-3.71 |
|
|
|
Dividend/ Interest Income |
0.08 |
|
9.45 |
|
|
|
Other Non operational
Income(+)/Expenses(-) |
-20.57 |
|
-7.77 |
|
|
|
Profit before tax |
150.14 |
|
-23.39 |
|
|
|
|
|
|
|
|
|
| 3 |
Capital Employed |
|
|
|
|
|
|
|
|
|
|
|
|
|
HealthCare |
6433.15 |
|
6433.15 |
|
|
|
|
|
|
|
|
|
|
Notes : |
|
|
|
|
|
|
1.The above results were reviewed
by the Audit committee and approved by the Board of Directors of the Company at its |
|
meeting held on 26th November 2003. |
|
|
|
|
|
|
2.
The Company's sole business segment is HealthCare. The capital employed in this segment is
Rs.9639.58 lakhs (12 months |
|
ended 31st December 2002
: Rs. 7,586.92 lakhs). The above results for 3 months and 9 months ended 30th September 2003 |
|
include non operational income (net of
non operational expense) Rs.15.40 lakhs (corresponding 3 months of previous year |
|
Rs.0.11 lakhs) and Rs. 99.16 lakhs (corresponding
9 months of previous year Rs. 47.17 lakhs) respectively (12 months |
|
ended 31st
December 2002: Rs. 46.93 lakhs). |
|
|
|
|
|
|
3. There was no investor complaint
pending as at the beginning of the quarter.The Company
received three investor |
|
|
complaints during the quarter ended 30th September, 2003. All the
complaints were satisfactorily dealt with. |
|
|
4.
Previous period figures have been regrouped/ reclassified, wherever necessary. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By Order of the Board of Directors |
|
|
For ASTRAZENECA PHARMA INDIA LIMITED |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LARS WALAN |
|
|
|
Managing Director |
|
|
| Bangalore |
|
|
|
|
|
| Dated |
: 26th November 2003 |
|
|
|
|
|
|
|
|
|
|
|
|
Back